References
- A study to evaluate the safety and efficacy of Omiganan (CLS001) topical gel versus vehicle in female subjects with moderate to severe acne vulgaris. ClinicalTrials.gov.
- Adegoke A.A., Faleye A.C., Singh G., Stenström T.A. (2017). Antibiotic resistant superbugs: assessment of the interrelationship of occurrence in clinical settings and environmental niches. Mol. Basel Switz., 22: 29.
- Ahmad V., Khan M.S., Jamal Q.M.S., Alzohairy M.A., Al Karaawi M.A., Siddiqui M.U. (2017). Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation. Int. J. Antimicrob. Agents, 49: 1–11.
- Alcock B.P., Raphenya A.R., Lau T.T.Y., Tsang K.K., Bouchard M., Edalatmand A., Huynh W., Nguyen A.-L.V., Cheng A.A., Liu S., etal. (2019). CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res., gkz935.10.1093/nar/gkz935714562431665441
- Allen H.K., Trachsel J., Looft T., Casey T.A. (2014). Finding alternatives to antibiotics. Ann. N. Y. Acad. Sci., 1323: 91–100.
- Aminov R.I. (2010). A brief history of the antibiotic era: lessons learned and challenges for the future. Front. Microbiol., 1: 134.
- Andam C.P., Fournier G.P., Gogarten J.P. (2011). Multilevel populations and the evolution of antibiotic resistance through horizontal gene transfer. FEMS Microbiol. Rev., 35: 756–767.
- Andrès E. (2012). Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol., 31: 881–888.
- Arseculeratne S.N., Arseculeratne G. (2017). A re-appraisal of the conventional history of antibiosis and Penicillin. Mycoses, 60: 343–347.
- Bagnicka E., Strzałkowska N., Jóźwik A., Krzyżewski J., Horbańczuk J., Zwierzchowski L. (2010). Expression and polymorphism of defensins in farm animals. Acta Biochim. Pol., 57: 487–497.
- Ball A.P., Gray J.A., Murdoch J.M. (1978). The natural penicillins – Benzylpenicillin (Penicillin G) and Phenoxymethylpenicillin (Penicillin V). In: Antibacterial drugs today. Ed. Springer, Dordrecht, pp. 6–18.10.1007/978-94-011-8004-7_3
- Barna J.C.J., Williams D.H. (1984). The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Ann. Rev. Microbiol., 38: 339–357.
- Bennett J.W., Chung K.T. (2001). Alexander Fleming and the discovery of penicillin. Adv. Appl. Microbiol., 49: 163–184.
- Bentley R. (1997). Microbial secondary metabolites play important roles in medicine; prospects for discovery of new drugs. Perspect. Biol. Med., 40: 364–394.
- Blair S.E., Cokcetin N.N., Harry E.J., Carter D.A. (2009). The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol., 28: 1199–1208.
- Borie C., Sánchez M.L., Navarro C., Ramírez S., Morales M.A., Retamales J., Robeson J. (2009). Aerosol spray treatment with bacteriophages and competitive exclusion reduces Salmonella Enteritidis infection in chickens. Avian Dis., 53: 250–254.
- Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.-C. (2005). In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. Off. J. Soc. Toxicol., 88: 412–419.
- Bruin J., Aar M.vander, Overdevest I., Kluytmans J., Diederen B. (2010). P24.06 Prevalence of highly resistant Enterobacteriaceae including ESBLs in retail meat. J. Hosp. Infect., 76: S69.
- Callaway T.R., Edrington T.S., Brabban A.D., Anderson R.C., Rossman M.L., Engler M.J., Carr M.A., Genovese K.J., Keen J.E., Looper M.L., Kutter E.M., Nisbet D.J. (2008). Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157: H7 populations in ruminant gastrointestinal tracts. Foodborne Pathog. Dis., 5: 183–191.
- Cars O., Hedin A., Heddini A. (2011). The global need for effective antibiotics-moving towards concerted action. Drug Resist. Updat., 14: 68–69.
- CDC–Centersfor Disease Controland Prevention(2019). The biggest antibiotic-resistant threats in the U.S. http://dx.doi.org/10.15620/cdc:8253210.15620/cdc:82532
- Chen C., Guron G.K., Pruden A., Ponder M., Du P., Xia K. (2018). Antibiotics and antibiotic resistance genes in bulk and rhizosphere soils subject to manure amendment and vegetable cultivation. J. Environ. Qual., 47: 1318–1326.
- Chopra I., Roberts M. (2001). Tetracycline antibiotics: mode of action, applications, molecular biology, epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev., 65: 232–260.
- Cirz R.T., Chin J.K., Andes D.R., de Crécy-Lagard V., Craig W.A., Romesberg F.E. (2005). Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol., 3: e176.
- Clark D.P., Durell S., Maloy W.L., Zasloff M. (1994). Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J. Biol. Chem., 269: 10849–10855.
- Cook K.L., Netthisinghe A.M.P., Gilfillen R.A. (2014). Detection of pathogens, indicators, antibiotic resistance genes after land application of poultry litter. J. Environ. Qual., 43: 1546.
- Coppo E., Del Bono V., Ventura F., Camera M., Orengo G., Viscoli C., Marchese A. (2014). Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. BMC Microbiol., 14: 148.
- Costerton J.W., Cheng K.J., Geesey G.G., Ladd T.I., Nickel J.C., Dasgupta M., Marrie T.J. (1987). Bacterial biofilms in nature and disease. Annu. Rev. Microbiol., 41: 435–464.
- Cotter P.D., Hill C., Ross R.P. (2005). Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol., 3: 777–788.
- Crispie F., Flynn J., Ross R.P., Hill C., Meaney W. (2004). Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147. Ir. Vet. J., 57: 652–656.
- Crispie F., Twomey D., Flynn J., Hill C., Ross P., Meaney W. (2005). The lantibiotic lacticin3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus. J. Dairy. Res., 72: 159–167.
- Cully M. (2014). Public health: The politics of antibiotics. Nature, 509: S16–S17.
- D’Agostino M., Tesse N., Frippiat J.P., Machouart M., Debourgogne A. (2019). Essential oils and their natural active compounds presenting antifungal properties. Molecules, 24: 3713.
- D’Costa V.M., King C.E., Kalan L., Morar M., Sung W.W.L., Schwarz C., Froese D., Zazula G., Calmels F., Debruyne R., etal. (2011). Antibiotic resistance is ancient. Nature, 477: 457–461.
- Dąbrowska K., Abedon S.T. (2019). Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies. Microbiol. Mol. Biol. Rev., 83.10.1128/MMBR.00012-19682299031666296
- Davies J., Davies D. (2010). Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev., 74: 417–433.
- de Breij A., Riool M., Cordfunke R.A., Malanovic N., de Boer L., Koning R.I., Ravensbergen E., Franken M., vander Heijde T., Boekema B.K., etal. (2018). The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci. Transl. Med., 10.
- de Jong J., Bos J.H.J., de Vries T.W., de Jong-vanden Berg L.T.W. (2014). Use of antibiotics in rural and urban regions in The Netherlands: an observational drug utilization study. BMC Public Health, 14: 677.
- De Smet K., Contreras R. (2005). Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett., 27: 1337–1347.
- Desai J.V., Mitchell A.P., Andes D.R. (2014). Fungal biofilms, drug resistance, recurrent infection. Cold Spring Harb. Perspect. Med., 4: a019729.
- Dibner J.J., Richards J.D. (2005). Antibiotic growth promoters in agriculture: history and mode of action. Poultry Sci., 84: 634–643.
- Djeraba A., Quere P. (2000). In vivo macrophage activation in chickens with Acemannan, a complex carbohydrate extracted from Aloe vera. Int. J. Immunopharmacol., 22: 365–372.
- Dowling P.M. (2013 a). Peptide Antibiotics. In: Antimicrobial Therapy in Veterinary Medicine. John Wiley & Sons, Ltd, pp. 189–198.10.1002/9781118675014.ch11
- Dowling P.M. (2013 b). Miscellaneous Antimicrobials. In: Antimicrobial Therapy in Veterinary Medicine. John Wiley & Sons, Ltd, pp. 315–332.10.1002/9781118675014.ch19
- Duckett S. (1999). Ernest Duchesne and the concept of fungal antibiotic therapy. Lancet Lond. Engl., 354: 2068–2071.
- Duewelhenke N., Krut O., Eysel P. (2007). Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob. Agents Chemother., 51: 54–63.
- Dufour D., Leung V., Lévesque C.M. (2010). Bacterial biofilm: structure, function, antimicrobial resistance. Endod. Top., 22: 2–16.
- Dwivedi S., Saquib Q., Al-Khedhairy A.A., Musarrat J. (2016). Understanding the role of nanomaterials in agriculture. In Microbial inoculants in sustainable agricultural productivity. Springer, New Delhi, pp. 271–288.10.1007/978-81-322-2644-4_17
- Fangio M.F., Orallo D.E., Gende L.B., Churio M.S. (2019). Chemical characterization and antimicrobial activity against Paenibacillus larvae of propolis from Buenos Aires province, Argentina. J. Aplic. Res., 58: 626–638.
- Field D., Gaudin N., Lyons F., O’Connor P.M., Cotter P.D., Hill C., Ross R.P. (2015). A bioengineered Nisin derivative to control biofilms of Staphylococcus pseudintermedius. PLoS One, 10: e0119684.
- Fleming A. (1929). On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ. Br. J. Exp. Pathol., 10: 226–236.
- Frieri M., Kumar K., Boutin A. (2017). Antibiotic resistance. J. Infect. Public Health, 10: 369–378.
- Fritsche T.R., Rhomberg P.R., Sader H.S., Jones R.N. (2008 a) Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections. Antimicrob. Agents Chemother., 52: 1187–1189.10.1128/AAC.01475-07225849518180345
- Fritsche T.R., Rhomberg P.R., Sader H.S., Jones R.N. (2008 b). Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. J. Antimicrob. Chemother., 61: 1092–1098.10.1093/jac/dkn07418310135
- Giguère S., Dowling P.M. (2013). Fluoroquinolones. In: Antimicrobial Therapy in Veterinary Medicine. John Wiley & Sons, Ltd, pp. 295–314.10.1002/9781118675014.ch18
- Godlewska M., Świsłocka R. (2015). The physicochemical and antimicrobial properties of honey from the region of Podlasie (in Polish). Kosmos, 64: 347–352.
- González-Mas M.C., Rambla J.L., López-Gresa M.P., Blázquez M.A., Granell A. (2019). Volatile compounds in citrus essential oils: a comprehensive review. Front. Plant Sci., 10.10.3389/fpls.2019.00012
- Grecka K., Kuś P.M., Okińczyc P., Worobo R.W., Walkusz J., Szweda P. (2019). The anti-staphylococcal potential of ethanolic Polish propolis extracts. Molecules, 24: 1732.
- Gucwa K., Milewski S., Dymerski T., Szweda P. (2018). Investigation of the antifungal activity and mode of action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus essential oils. Molecules, 23: 1116.
- Hancock R.E. (1997). Peptide antibiotics. Lancet Lond. Engl., 349: 418–422.
- Heuer H., Schmitt H., Smalla K. (2011). Antibiotic resistance gene spread due to manure application on agricultural fields. Curr. Opin. Microbiol., 14: 236–243.
- Hoffman S.J., Outterson K., Røttingen J.-A., Cars O., Clift C., Rizvi Z., Rot-berg F., Tomson G., Zorzet A. (2015). An international legal framework to address antimicrobial resistance. Bull. World Health Organ., 93: 66.
- Holmes A.H., Moore L.S.P., Sundsfjord A., Steinbakk M., Regmi S., Karkey A., Guerin P.J., Piddock L.J.V. (2016). Understanding the mechanisms and drivers of antimicrobial resistance. Lancet, 387: 176–187.
- Ibrahim M.E., Bilal N.E., Hamid M.E. (2012). Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan. Afr. Health Sci., 12: 368–375.
- Jamal M., Ahmad W., Andleeb S., Jalil F., Imran M., Nawaz M.A., Hussain T., Ali M., Rafiq M., Kamil M.A. (2018). Bacterial biofilm and associated infections. J. Chin. Med. Assoc., 81: 7–11.
- Jarczak J., Kościuczuk E.M., Lisowski P., Strzałkowska N., Jóźwik A., Horbań-czuk J., Krzyżewski J., Zwierzchowski L., Bagnicka E. (2013). Defensins: natural component of human innate immunity. Hum. Immunol., 74: 1069–1079.
- Jones O.A., Lester J.N., Voulvoulis N. (2005). Pharmaceuticals: a threat to drinking water? Trends Biotechnol., 23: 163–167.
- Jouanna J. (2012). Greek medicine from Hippocrates to Galen: Selected papers. Brill.10.1163/9789004232549
- Kapoor G., Saigal S., Elongavan A. (2017). Action and resistance mechanisms of antibiotics: A guide for clinicians. J. Anaesthesiol. Clin. Pharmacol., 33: 300–305.
- Khan S.U., Anjum S.I., Rahman K., Ansari M.J., Khan W.U., Kamal S., Khattak B., Muhammad A., Khan H.U. (2018). Honey: Single food stuff comprises many drugs. Saudi J. Biol. Sci., 25: 320–325.
- Kim K.H., Ingale S.L., Kim J.S., Lee S.H., Lee J.H., Kwon I.K., Chae B.J. (2014). Bacteriophage and probiotics both enhance the performance of growing pigs but bacteriophage are more effective. Anim. Feed. Sci. Tech., 196: 88–95.
- Klostermann K., Crispie F., Flynn J., Meaney W.J., Paul R.R., Hill C. (2010). Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis. J. Dairy. Res., 77: 231–238.
- Kon K., Rai M. (2016). Antibiotic resistance: mechanisms and new antimicrobial approaches. Academic Press.
- Kościuczuk E.M., Lisowski P., Jarczak J., Strzałkowska N., Jóźwik A., Horbań-czuk J., Krzyżewski J., Zwierzchowski L., Bagnicka, E. (2012). Cathelicidins: family of antimicrobial peptides. A review. Mol. Biol. Rep., 39: 10957–10970.
- Kouidhi B., Al Qurashi Y.M.A., Chaieb K. (2015). Drug resistance of bacterial dental biofilm and the potential use of natural compounds as alternative for prevention and treatment. Microb. Pathog., 80: 39–49.
- Kubicki J. (2013). History of the syphilis (in Polish). Puls Uczel., 3: 37–39.
- Kurek A., Grudniak A.M., Kraczkiewicz-Dowjat A., Wolska K.I. (2011). New antibacterial therapeutics and strategies. Pol. J. Microbiol., 60: 3–12.
- Kuś P.M., Szweda P., Jerković I., Tuberoso C.I.G. (2016). Activity of Polish unifloral honeys against pathogenic bacteria and its correlation with colour, phenolic content, antioxidant capacity and other parameters. Lett. Appl. Microbiol., 62: 269–276.
- Landecker H. (2016). Antibiotic resistance and the biology of history. Body Soc., 22: 19–52.
- Levy S.B., Marshall B. (2004). Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med., 10: 122–129.
- Lewis K. (2001). Riddle of biofilm resistance. Antimicrob. Agents Chemother., 45: 999–1007.
- Liu B., Pop M. (2009). ARDB – Antibiotic Resistance Genes Database. Nucleic Acids Res., 37: D443–D447.
- Lloyd D.H. (2012). Alternatives to conventional antimicrobial drugs: a review of future prospects. Vet. Dermatol., 23: 299–304, e59–60.
- Loc-Carrillo C., Abedon S.T. (2011). Pros and cons of phage therapy. Bacteriophage, 1: 111–114.
- Lopez-Carrizales M., Velasco K.I., Castillo C., Flores A., Magaña M., Martinez-Castanon G.A., Martinez-Gutierrez F. (2018). In vitro synergism of silver nanoparticles with antibiotics as an alternative treatment in multiresistant uropathogens. Antibiot. Basel Switz., 7: 50.
- Mac Fadden D.R., Mc Gough S.F., Fisman D., Santillana M., Brownstein J.S. (2018). Antibiotic resistance increases with local temperature. Nat. Clim. Change, 8: 510–514.
- Mahlapuu M., Håkansson J., Ringstad L., Björn C. (2016). Antimicrobial peptides: an emerging category of therapeutic agents. Front. Cell. Infect. Microbiol., 6: 194.
- Mao X.F., Piao X.S., Lai C.H., Li D.F., Xing J.J., Shi B.L. (2005). Effects of β-glucan obtained from the Chinese herb Astragalus membranaceus and lipopolysaccharide challenge on performance, immunological, adrenal, somatotropic responses of weanling pigs. J. Anim. Sci., 83: 2775–2782.
- Martínez J.L., Baquero F., Andersson D.I. (2007). Predicting antibiotic resistance. Nat. Rev. Microbiol., 5: 958–965.
- Miller R.W., Skinner J., Sulakvelidze A., Mathis G.F., Hofacre C.L. (2010). Bacteriophage therapy for control of necrotic enteritis of broiler chickens experimentally infected with Clostridium perfringens. Avian Dis., 54: 33–40.
- Moellering R.C. (2011). Discovering new antimicrobial agents. Int. J. Antimicrob. Agents, 37: 2–9.
- Mohr K.I. (2016). History of antibiotics research. In: How to overcome the antibiotic crisis, M. Stadler, P. Dersch, eds. Cham, Springer International Publishing, pp. 237–272.10.1007/82_2016_499
- Naafs M.A.B. (2018). The antimicrobial peptides: ready for clinical trials? Biomed. J. Sci. Tech. Res., 7: 6038–6042.
- Nam S., Choi Y., Jang S., Shim Y., Han G. (2016). Antimicrobial activity of propolis on different oral bacteria. Indian J. Sci. Technol., 9: 1–4.
- Namkung H., Li M., Gong J., Yu H., Cottrill M., de Lange C.F.M. (2004). Impact of feeding blends of organic acids and herbal extracts on growth performance, gut microbiota and digestive function in newly weaned pigs. Can. J. Anim. Sci., 84: 697–704.
- Nishie M., Nagao J.-I., Sonomoto K. (2012). Antibacterial peptides “bacteriocins”: an overview of their diverse characteristics and applications. Biocontrol. Sci., 17: 1–16.
- Nobrega F.L., Costa A.R., Kluskens L.D., Azeredo J. (2015). Revisiting phage therapy: new applications for old resources. Trends Microbiol., 23: 185–191.
- Oliveira A.V., Ferreira A.L., Nunes S., Dandlen S.A., Miguel M.D.G., Faleiro M.L. (2017). Antibacterial activity of propolis extracts from the south of Portugal. Pak. J. Pharm. Sci., 30.
- Overdevest I., Willemsen I., Rijnsburger M., Eustace A., Xu L., Hawkey P., Heck M., Savelkoul P., Vandenbroucke-Grauls C., vander Zwaluw K., etal. (2011). Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg. Infect. Dis., 17: 1216–1222.
- Pajor M., Worobo R.W., Milewski S., Szweda P. (2018). The antimicrobial potential of bacteria isolated from honey samples produced in the apiaries located in Pomeranian Voivodeship in Northern Poland. Int. J. Environ. Res. Public. Health, 15.10.3390/ijerph15092002
- Peacock S.J., Paterson G.K. (2015). Mechanisms of methicillin resistance in Staphylococcus aureus. Annu. Rev. Biochem., 84: 577–601.
- Peterson E., Kaur P. (2018). Antibiotic resistance mechanisms in bacteria: relationships between resistance determinants of antibiotic producers, environmental bacteria, clinical pathogens. Front. Microbiol., 9.10.3389/fmicb.2018.02928
- Pirisi A. (2000). Phage therapy – advantages over antibiotics? Lancet, 356: 1418.10.1016/S0140-6736(05)74059-9
- Pouillard J. (2002). A forgotten discovery: doctor of medicine Ernest Duchesne’s thesis (1874–1912). Hist. Sci. Medicales, 36: 11–20.
- Prescott J.F. (2013). Beta-lactam antibiotics. In: Antimicrobial therapy in veterinary medicine. John Wiley & Sons, Ltd, pp. 153–173.
- Prystowsky J., Siddiqui F., Chosay J., Shinabarger D.L., Millichap J., Peter-son L.R., Noskin G.A. (2001). Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob. Agents Chemother., 45: 2154–2156.
- Przybyłek I., Karpiński T.M. (2019). Antibacterial properties of propolis. Molecules, 24: 2047.
- Raut J.S., Karuppayil S.M. (2014). A status review on the medicinal properties of essential oils. Ind. Crops Prod., 62: 250–264.
- Roccanova L., Rappa P. (2000). Antibiotic rotation. Science, 287: 803.
- Sagdic O., Ekici L., Ozturk I., Tekinay T., Polat B., Tastemur B., Bayram O., Senturk B. (2013). Cytotoxic and bioactive properties of different color tulip flowers and degradation kinetic of tulip flower anthocyanins. Food Chem. Toxicol., 58: 432–439.
- Satpathy S., Sen S.K., Pattanaik S., Raut S. (2016). Review on bacterial biofilm: An universal cause of contamination. Biocatal. Agric. Biotechnol., 7: 56–66.
- Schwarz S., Shen J., Kadlec K., Wang Y., Brenner Michael G., Feßler A.T., Vester B. (2016). Lincosamides, streptogramins, phenicols, pleuromutilins: mode of action and mechanisms of resistance. Cold Spring Harb. Perspect. Med., 6.10.1101/cshperspect.a027037508850827549310
- Shama G. (2016). La Moisissure et la Bactérie: Deconstructing the fable of the discovery of penicillin by Ernest Duchesne. Endeavour, 40: 188–200.
- Singer A.C., Shaw H., Rhodes V., Hart A. (2016). Review of antimicrobial resistance in the environment and its relevance to environmental regulators. Front. Microbiol., 7.10.3389/fmicb.2016.01728508850127847505
- Singh B., Sharma R.A. (2015). Anti-inflammatory and antimicrobial properties of flavonoids from heliotropium subulatum exudate. Inflamm. Allergy Drug Targets, 14: 125–132.
- Stefani S., Varaldo P.E. (2003). Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect., 9: 1179–1186.
- Study of Omiganan 1% gel in preventing catheter infections/colonization in patients with central venous catheters. ClinicalTrials.gov.
- Szweda P., Gucwa K., Kurzyk E., Romanowska E., Dzierżanowska-Fangrat K., Zielińska-Jurek A., Kuś P.M., Milewski S. (2015). Essential oils, silver nanoparticles and propolis as alternative agents against fluconazole resistant Candida albicans, Candida glabrata and Candida krusei clinical isolates. Indian J. Microbiol., 55: 175–183.
- Szweda P., Zalewska M., Pilch J., Kot B., Milewski S. (2018). Essential oils as potential anti-staphylococcal agents. Acta Vet. Beogr., 68: 95–107.
- The European Union Summary Reportonantimicrobialresistanceinzoonoticandindicatorbacteriafromhumans, animalsandfoodin2012(2014). EFSA J., 12: 3590.
- Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia. ClinicalTrials.gov.
- von Wintersdorff C.J.H., Penders J., van Niekerk J.M., Mills N.D., Majumder S., van Alphen L.B., Savelkoul P.H.M., Wolffs P.F.G. (2016). Dissemination of antimicrobial resistance in microbial ecosystems through horizontal gene transfer. Front. Microbiol., 7: 173.
- Waihenya R.K., Mtambo M.M.A., Nkwengulila G., Minga U.M. (2002). Efficacy of crude extract of Aloe secundiflora against Salmonella gallinarum in experimentally infected freerange chickens in Tanzania. J. Ethnopharmacol., 79: 317–323.
- Wainwright M. (1985). Re-examination of some of John Tyndall’s studies on microbial antagonism. Trans. Br. Mycol. Soc., 85: 526–529.
- Waksman S.A. (1947). What is an antibiotic or an antibiotic substance? Mycologia, 39: 565–569.10.1080/00275514.1947.12017635
- Wang F.-H., Qiao M., Chen Z., Su J.-Q., Zhu Y.-G. (2015). Antibiotic resistance genes in manure- amended soil and vegetables at harvest. J. Hazard. Mater., 299: 215–221.
- Wattam A.R., Davis J.J., Assaf R., Boisvert S., Brettin T., Bun C., Conrad N., Dietrich E.M., Disz T., Gabbard J.L., etal. (2017). Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center. Nucleic Acids Res., 45: D535–D542.
- Weston R.J. (2000). The contribution of catalase and other natural products to the antibacterial activity of honey: a review. Food Chem., 71: 235–239.
- Woc-Colburn L., Francisco D.M.A. (2020). Multidrug resistance bacterial infection. In: Highly infectious diseases in critical care: a comprehensive clinical guide, J. Hidalgo, L. Woc-Colburn, eds. Cham: Springer International Publishing, pp. 139–146.10.1007/978-3-030-33803-9_8
- Wolf E.P., Lewis J.H. (1919) The effect of feeding yeast on antibody production. Int. J. Infect. Dis., 25: 311–314.
- Wolny-Koładka K., Sikora A., Malina D. (2018). Evaluation of silver nanoparticles toxicity to drug-resistant Escherichia coli strains isolated from municipal waste (in Polish). Infrastruktura Ekol. Teren. Wiej., 1: 7:23.
- Wrigley S., Hayes M., Thomas R., Chrystal E.J.T., Nicholson N. (2000). Biodiversity: new leads for the pharmaceutical and agrochemical industries. Royal Society of Chemistry.
- Yoon K.-Y., Hoon Byeon J., Park J.-H., Hwang J. (2007). Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci. Total Environ., 373: 572–575.
- Zalewska M., Churey J.J., Worobo R.W., Milewski S., Szweda P. (2018). Isolation of bacteriocin-producing Staphylococcus spp. strains from human skin wounds, soft tissue infections and bovine mastitis. Pol. J. Microbiol., 67: 163–169.
- Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., Aarestrup F.M., Larsen M.V. (2012). Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother., 67: 2640–2644.